Drugs with this side effect as MedDRA Preferred Term
- D-cycloserine
- K779
- Aggression
- Aggressive reaction
- VACV
- Aggression: postmarketing
- Zyprexa Relprevv
- acyclovir
- Aggression: postmarketing
- agomelatine
- alprazolam
- amantadine
- Aggression: postmarketing
- amisulpride
- amphetamine
- aripiprazole
- atenolol
- Aggression: postmarketing
- atomoxetine
- Aggression: postmarketing
- azithromycin
- Aggressive reaction: postmarketing
- beclomethasone
- bleomycin hydrochloride
- boceprevir
- bromazepam
- Aggression: postmarketing
- bupropion
- Aggression: postmarketing
- cabergoline
- Aggression: postmarketing
- carbamazepine
- cetirizine
- Aggression: postmarketing
- Aggressive reaction: postmarketing
- cevimeline
- citalopram
- Aggression: postmarketing, rare
- Aggressive reaction: infrequent, uncommon
- clobazam
- clomipramine
- Aggression: common
- Aggressive reaction: 2%
- clonazepam
- Aggression: 1.4%
- Aggressive reaction
- clonidine
- cyclobenzaprine
- Aggression: postmarketing
- delamanid
- deprenyl
- Aggressive reaction: postmarketing
- desmopressin
- diazepam
- donepezil
- Aggression: postmarketing, frequent, 4.3% - 7%
- doxepin
- duloxetine
- Aggression: very rare, postmarketing
- efavirenz
- Aggression: uncommon, 0.3% - 0.4%
- ertapenem
- Aggression: postmarketing
- esomeprazole magnesium
- Aggression: postmarketing
- ethosuximide
- everolimus
- Aggression: uncommon, 0% - 21%
- felbamate
- Aggressive reaction: frequent
- flumazenil
- flunitrazepam
- Aggression: postmarketing
- fluoxetine
- Aggression
- Violent: postmarketing
- fluphenazine decanoate
- fluticasone
- Aggression: postmarketing
- fluvoxamine
- Aggression: postmarketing
- foscarnet
- galantamine
- Aggression: postmarketing, infrequent
- Aggressive reaction
- gliclazide
- glimepiride
- glycopyrrolate
- hydromorphone
- iloperidone
- imipramine
- lacosamide
- Aggression: postmarketing
- levetiracetam
- Aggression: postmarketing, 10%
- lisdexamfetamine dimesylate
- Aggression: postmarketing
- lisuride
- lorazepam
- lormetazepam
- maprotiline
- mefloquine
- Aggression: postmarketing
- melatonin
- memantine
- Aggression: 2%
- Aggressive reaction: frequent
- methsuximide
- methylphenidate
- Aggression: postmarketing, 1.2% - 1.7%
- midazolam
- Aggression
- Aggressive reaction
- Argumentativeness
- milnacipran
- Aggression: postmarketing
- mirtazapine
- Aggression: postmarketing
- mitotane
- moclobemide
- modafinil
- Aggression: postmarketing
- montelukast
- Aggression: postmarketing
- Temper tantrum
- naratriptan
- nitrazepam
- Aggression
- Violent behavior
- norepinephrine
- ofloxacin
- Aggression: postmarketing
- omeprazole
- Aggression: postmarketing, rare
- oxazepam
- oxcarbazepine
- paliperidone
- paroxetine
- Aggression: postmarketing
- perampanel
- pindolol
- pramipexole
- pregabalin
- progesterone
- Aggression: postmarketing
- propericiazine
- quetiapine
- retinoic acid
- Aggression: postmarketing
- Violent: postmarketing
- Violent behavior: postmarketing
- ribavirin
- rifapentine
- rimonabant
- risperidone
- Aggressive reaction: 1% - 3%
- rivastigmine
- Aggression: postmarketing, uncommon, frequent, 0.4% - 3%
- Aggressive reaction: 3%
- ropinirole
- Aggressive reaction: infrequent, frequent
- rotigotine
- rufinamide
- salbutamol
- sertraline
- Aggression
- Aggressive reaction: postmarketing, infrequent, 1.6%
- stiripentol
- streptozotocin
- sumatriptan
- temazepam
- testosterone
- Aggression: postmarketing, 1.31%
- testosterone enanthate
- Aggression: postmarketing
- testosterone propionate
- testosterone undecanoate
- topiramate
- Aggression: very rare, postmarketing, 2.8% - 8.7%
- Aggressive reaction: 0% - 9.2%
- triazolam
- valproate
- Aggression: postmarketing
- varenicline
- Aggression: postmarketing, infrequent
- venlafaxine
- vigabatrin
- Aggression: common, 5%
- Aggressive reaction
- zaleplon
- ziconotide
- zolpidem
- Aggression: postmarketing, rare
- Aggressive reaction: rare
- zonisamide
- zopiclone
|
Drugs with this indication
|